Search the webpage

Created by Leona Damalakienė on  October 7, 2019  in category: News

Optical Coherence Tomography Angiography (OCT-A) is a novel non-invasive imaging technique to generate high resolution images of the retinal and choroidal microvasculature. By using motion contrast imaging, OCT-A can generate angiographic images without the need for intravenous dye injection.

At Experimentica, we are now implementing the use of OCT-A to quantify disease-associated changes in the microvasculature. Leveraging our ongoing efforts in artificial intelligence (AI) and machine learning, we anticipate that rodent OCT-A images will further improve the translatability from preclinical disease models in the very near future.



The OCT-A scans shown here were captured using the Spectralis® OCT-A module (Heidelberg Engineering, Germany). The animation shows the 3D rendering of a single scan from a naïve rat with representative still images obtained from the superficial vascular complex and the deep capillary plexus.   


Contact for media enquiries:

Dr. Leona Damalakiene
R&D Director
Experimentica Ltd.
Phone: +370 (686) 14 280


Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019

We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on ... Read More

Experimentica Ltd. is a member of BioMelbourne Network

We are delighted to become a member of BioMelbourne Network together with other committed organisations engaged in biotechnology, medical technology, ... Read More

Let’s meet at Global Biotech VIP Week in Melbourne, 2019

Experimentica’s CEO Giedrius Kalesnykas attends Global Biotech VIP Week in Melbourne, Australia, sponsored by Global Victoria, and participates in AusBiotech ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!